HUBZone Owned: N. Socially and Economically Disadvantaged: N. Woman Owned: N. Award Charts. Contact: Industry. At Precision BioSciences. The Company offers treatments for cancer. (C) 2020 Electronic News Publishing, source ENP Newswire, Precision BioSciences to Present at Upcoming Virtual Investor Conferences in October. .css('align-items', 'center') www.vbprofiles.com is now www.topionetworks.com. A key update from the U.S. Food and Drug Administration (FDA) boosted Precision BioSciences Inc. (NASDAQ: DTIL) shares early on Wednesday. Gene therapies have the power to treat disease at the DNA level and address severe unmet medical needs. .css('margin', '0 15px') Chief Medical Officer Chris Heery has said that he is looking forward to working more closely with the FDA as the firm continues to investigate PBCAR269A as a potential new treatment option that can be more broadly available to patients who otherwise may be ineligible or unable to access existing autologous CAR T therapies. Founded. INDUSTRY. Ownership Information. FOUNDED. Award Listing. The Flinn Foundation supports the biosciences in Arizona through research grants and stewardship of Arizona’s Bioscience Roadmap, released in 2002 and guiding the growth and development of the state’s bioscience sector through 2025.. At Precision BioSciences, leaders in genome editing utilize the ARCUS® editing platform to eliminate cancers, cure genetic diseases, and create safer, more productive food sources. Socially and Economically Disadvantaged: N. DESCRIPTION (provided by applicant):Many of the most valuable pharmaceuticals on the market or undergoing clinical trials are glycoproteins. Alec holds a Ph.D. in plant molecular genetics from Virginia Tech. 919.314.5512. ARCUS is a highly specific and versatile genome editing platform designed … jQuery('.alert-icon') Multiple locations. }); Health Care. Precision BioSciences to Present at Upcoming Virtual Investor Conferences in .. Precision is developing genome editing-based products to address critical needs in human health, agriculture, and beyond. This is the firm’s second allogeneic chimeric antigen receptor (CAR T) cell therapy to receive Fast Track Designation for which the FDA previously granted Orphan Drug Designation. .css('font-size', '12px'); Phone. Unlike some gene editing technologies that were designed primarily as research tools and subsequently engineered for therapeutic use, ARCUS was designed with therapeutic safety, delivery and control in mind. Small. At Precision BioSciences. we are focused on applying our proprietary ARCUS genome editing technology to cure genetic and infectious diseases where no adequate treatments exist. Address PRECISION BIOSCIENCES, INC. Precision BioSciences utilizes its proprietary ARCUS Genome Editing method to overcome cancers, cure genetic diseases, and enable development of safer food. 302 East Pettigrew St. Durham, NC 27701. 302 E Pettigrew St Dibrell Bld Suite A- 100 Durham, NC 27701 United States. .css('color', '#1b1e29') Precision BioSciences management noted that the designation will help it expedite the allogeneic CAR T cell therapy program aimed to address the unmet medical need among patients with relapsed/refractory multiple myeloma. Precision Bioservices Inc Precision Bioservices, Inc. was founded in 2012. We believe our ARCUS platform has several significant advantages for use directly in vivo: We have developed a robust pipeline of gene correction therapy candidates with a focus on diseases that have a clearly established genetic cause. jQuery("header").prepend(warning_html); .css('text-decoration', 'underline') jQuery('.alert-content') Precision BioSciences’ vision is to be the conduit through which the greatest genome engineering challenges are solved. $10M to $25M. .css('padding', '15px 5px') Precision BioSciences leverages ARCUS in the development of its product candidates, which are designed to treat human diseases and create healthy and sustainable food and agriculture solutions. ADDRESS. Information. Website. (Address, including zip code, and telephone number, including area code, of registrant’s principal executive offices) Matthew Kane President and Chief Executive Officer Precision BioSciences, Inc. 302 East Pettigrew St., Suite A-100 Durham, North Carolina 27701 (919) 314-5512 (Name, address, including zip code, and telephone number, including .css('font-weight', '700') Precision Biosciences, Inc. operates as a biotech company. PRECISION BIOSCIENCES, INC. Company Information. 480.393.5553. To address agricultural needs, Elo partners with stakeholders in the food systems value chain to bridge gaps and meet needs across agricultural productivity, nutritional demand, food security, climate-resilience, and human wellness. 'I look forward to joining the incredibly talented group at Elo, working to create sustainable production of a more nutritious, and climate-resilient food supply.'. For more information on our Cookie Policy, including an opt-out, please click the "Cookie Policy" button. Prior to joining Elo, Alec served as the Technical Director of Agricultural Technologies at The Coca-Cola Company in Atlanta. Life Science Equipment. United States, Precision BioSciences to Present at Upcoming Virtual Investor Conferences in October, Elo Life Systems Appoints Food and Beverage Industry Technology Leader Alec Hayes as Vice President of Technology and Products, Precision BioSciences and SpringWorks Therapeutics Announce Clinical Collaboration to Evaluate PBCAR269A in Combination with, Precision BioSciences and Servier Expand CAR T Oncology Development Collaboration with Four New Programs Targeting Hematological, Precision Biosciences: Precision BioSciences and Servier Expand CAR T Oncology Development Collaboration with Four New Programs, Precision BioSciences Receives Fast Track Designation from U.S. Food and Drug Administration for PBCAR269A, an Investigational, Precision BioSciences to Present at Upcoming Virtual Investor Conferences in September, Precision BioSciences Receives Fast Track Disease Designation from U.S. Food and Drug Administration for PBCAR0191, Precision BioSciences Reports Second Quarter 2020 Financial Results and Provides Business Update, Elo Life Systems Announces Strategic Partnership with Dole Food Company with the Goal of Saving the Cavendish Banana. SUB-INDUSTRY. 'Alec's experience at the nexus of food and human health will be instrumental as we fast-track Elo's pipeline and long-term vision.